Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy.

Summary, in English

Opiate substitution treatment (OST) programs could provide opportunities for management of comorbidities, such as hepatitis C virus (HCV) infection, in people who inject drugs. We aimed to prospectively evaluate the real-life feasibility of interferon/ribavirin-based HCV treatment in OST recipients, with a special focus on psychiatric status and health-related quality of life.

• Author: Anna Jerkeman; Gunnar Norkrans; Christer Lidman; Johan Westin; Martin Lagging; Jan Frimand; Christian Simonsberg; Johan Kakko; Anders Widell; Per Björkman
• Department/s: Infectious Diseases Research Unit; Clinical Microbiology, Malmö
• Publishing year: 2014
• Language: English
• Pages: 523-531
• Publication/Series: European Journal of Gastroenterology and Hepathology
• Volume: 26
• Issue: 5
• Links: http://www.ncbi.nlm.nih.gov/pubmed/24637496?dopt=Abstract; http://dx.doi.org/10.1097/MEG.0000000000000076
• Document type: Journal article
• Publisher: Lippincott Williams & Wilkins
• Topic: Gastroenterology and Hepatology
• Status: Published
• Research group: Infectious Diseases Research Unit; Clinical Microbiology, Malmö
• ISBN/ISSN/Other: ISSN: 1473-5687